Discover the complete record of transactions filed by Erik Kullgren, Chief Financial Officer. Insider active across 2 companies, notably Alzinova AB. Aggregated, 5 filings have been published. Activity tracked since 2 April 2025. The latest transaction was disclosed on 1 April 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
20,000 shares@ €0.18970.0056% mcap17.6% of flowAktieFI:A003N138-1
Ideal exit: 28 Dec 2025 (T+270)
5 of 5 declarations
About Erik Kullgren
Erik Kullgren is the Chief Financial Officer of Alzinova AB, a company specializing in the development of treatments for neurodegenerative diseases. In his role, he is responsible for financial management and the company's financial strategy. Erik has a strong background in the sector, enabling him to contribute effectively to the growth and sustainability of Alzinova. His financial expertise is essential to support the company's strategic objectives.